Silo Pharma (SILO) Current Deferred Revenue (2021 - 2025)
Silo Pharma (SILO) has disclosed Current Deferred Revenue for 5 consecutive years, with $72102.0 as the latest value for Q4 2025.
- Quarterly Current Deferred Revenue changed 0.0% to $72102.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $72102.0 through Dec 2025, changed 0.0% year-over-year, with the annual reading at $72102.0 for FY2025, 0.0% changed from the prior year.
- Current Deferred Revenue hit $72102.0 in Q4 2025 for Silo Pharma, roughly flat from $72102.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $1.0 million in Q1 2021 to a low of $1676.0 in Q2 2024.
- Historically, Current Deferred Revenue has averaged $305454.4 across 5 years, with a median of $72102.0 in 2021.
- Biggest five-year swings in Current Deferred Revenue: crashed 95.12% in 2024 and later surged 4202.03% in 2025.
- Year by year, Current Deferred Revenue stood at $72102.0 in 2021, then changed by 0.0% to $72102.0 in 2022, then changed by 0.0% to $72102.0 in 2023, then changed by 0.0% to $72102.0 in 2024, then changed by 0.0% to $72102.0 in 2025.
- Business Quant data shows Current Deferred Revenue for SILO at $72102.0 in Q4 2025, $72102.0 in Q3 2025, and $72102.0 in Q2 2025.